
Huiliao Biotech
慧疗生物
Huiliao Biotech
Biotech/Healthcare
Built on its proprietary integrated platform spanning nucleic acid design and synthesis, delivery systems, and manufacturing processes, the company is developing an internationally leading, independently commercialized nucleic acid drug platform. It provides technical services for novel nucleic…
Latest round: Pre Series A (2023)
Source: ChinaBulls — chinabulls.com
Last updated 2023-03-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.